{"filing":{"accession_number":"0001808805-26-000027","cik":"0001808805","ticker":"NAUT","company_name":"Nautilus Biotechnology, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"naut-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880526000027/naut-20260617.htm"},"events":[{"id":11816,"run_id":10394,"accession_number":"0001808805-26-000027","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Nautilus Biotechnology's June 17, 2026 annual meeting, covering four matters: election of Class II directors (Parag Mallick and Farzad Nazem), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, and advisory vote on frequency of future Say on Pay votes. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","company_name":"Nautilus Biotechnology, Inc.","ticker":"NAUT","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8501,"accession_number":"0001808805-26-000027","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Nautilus Biotechnology's June 17, 2026 annual meeting, covering four matters: election of Class II directors (Parag Mallick and Farzad Nazem), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, and advisory vote on frequency of future Say on Pay votes. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:08:22.878573+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8501,"accession_number":"0001808805-26-000027","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Nautilus Biotechnology's June 17, 2026 annual meeting, covering four matters: election of Class II directors (Parag Mallick and Farzad Nazem), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, and advisory vote on frequency of future Say on Pay votes. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:08:22.878573+00:00","company_name":"Nautilus Biotechnology, Inc.","ticker":"NAUT","filing_date":"2026-06-18"}]}